KalVista Pharmaceuticals
KALV
KALV
144 hedge funds and large institutions have $714M invested in KalVista Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 48 increasing their positions, 38 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6.53% more ownership
Funds ownership: 109.51% → 116.05% (+6.5%)
4% more funds holding
Funds holding: 138 → 144 (+6)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
144
Holding in Top 10
2
Calls
$14.1M
Puts
$10.6M
Top Buyers
| 1 | +$21.4M | |
| 2 | +$20.3M | |
| 3 | +$12.9M | |
| 4 |
FGP
Freestone Grove Partners
San Francisco,
California
|
+$8.58M |
| 5 |
SCM
Sio Capital Management
New York
|
+$8.33M |
Top Sellers
| 1 | -$47.8M | |
| 2 | -$11.1M | |
| 3 | -$5.71M | |
| 4 |
SC
Stempoint Capital
New York
|
-$4.02M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.65M |
